Literature DB >> 2819286

Dry eye syndrome in long-term follow-up of bone marrow transplanted patients.

B Calissendorff1, M el Azazi, B Lönnqvist.   

Abstract

Out of 77 bone marrow transplanted patients surviving at least 1 year, 43% developed ocular manifestations of the sicca syndrome. This reaction was more frequent in patients with graft-versus-host disease (GVHD). Kerato-conjunctivitis sicca (KCS) developed in 28 patients (54%) who had survived acute GVHD but in only five cases (20%) of those without that complication. The incidence of dry eyes was 62% in the chronic GVHD group. All seven sicca cases in patients with aplastic anemia were seen in patients with chronic GVHD, while 10 out of 26 patients with hematological malignancies and without chronic GVHD had KCS. Two of these had not experienced any acute GVHD. Irradiation may contribute to the development of KCS, since all patients with hematological malignancies, in contrast to aplastic anemia patients, had undergone total body irradiation.

Entities:  

Mesh:

Year:  1989        PMID: 2819286

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  15 in total

1.  Immune recovery disease: a case of interstitial keratitis and tonic pupil following bone marrow transplantation.

Authors:  A S Ioannidis; M Forrest; K K Nischal; P Veys; E G Davies; G Woodruff
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

Review 2.  Effect of inflammation on lacrimal gland function.

Authors:  Driss Zoukhri
Journal:  Exp Eye Res       Date:  2005-11-23       Impact factor: 3.467

3.  Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation.

Authors:  Matin M Imanguli; Jane C Atkinson; Sandra A Mitchell; Daniele N Avila; Rachel J Bishop; Edward W Cowen; Manuel B Datiles; Frances T Hakim; David E Kleiner; Michael C Krumlauf; Steven Z Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-28       Impact factor: 5.742

4.  Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease.

Authors:  Jianyu Weng; Chang He; Peilong Lai; Chenwei Luo; Rong Guo; Suijing Wu; Suxia Geng; Andy Xiangpeng; Xialin Liu; Xin Du
Journal:  Mol Ther       Date:  2012-10-16       Impact factor: 11.454

5.  Dry eye after haematopoietic stem cell transplantation.

Authors:  Y Ogawa; S Okamoto; M Wakui; R Watanabe; M Yamada; M Yoshino; M Ono; H Y Yang; Y Mashima; Y Oguchi; Y Ikeda; K Tsubota
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

6.  Detection of BrdU-label retaining cells in the lacrimal gland: implications for tissue repair.

Authors:  Samantha You; Ayesha Tariq; Claire L Kublin; Driss Zoukhri
Journal:  Cell Tissue Res       Date:  2011-11-19       Impact factor: 5.249

7.  Simultaneous evaluation of tear turnover and corneal epithelial permeability by fluorophotometry in normal subjects and patients with keratoconjunctivitis sicca (KCS).

Authors:  J D Nelson
Journal:  Trans Am Ophthalmol Soc       Date:  1995

8.  Validation of measurement scales in ocular graft-versus-host disease.

Authors:  Yoshihiro Inamoto; Xiaoyu Chai; Brenda F Kurland; Corey Cutler; Mary E D Flowers; Jeanne M Palmer; Paul A Carpenter; Mary J Heffernan; David Jacobsohn; Madan H Jagasia; Joseph Pidala; Nandita Khera; Georgia B Vogelsang; Daniel Weisdorf; Paul J Martin; Steven Z Pavletic; Stephanie J Lee
Journal:  Ophthalmology       Date:  2011-12-06       Impact factor: 12.079

9.  Ocular complications in children after hematopoietic stem cell transplantation without total body irradiation.

Authors:  Michael Kinori; Bella Bielorai; Daniel Souroujon; Dafna Hutt; Iris Ben-Bassat Mizrachi; Ruth Huna-Baron
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-24       Impact factor: 3.117

10.  Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease.

Authors:  Kikuchi Takahide; Pablo M Parker; Michael Wu; William Y K Hwang; Paul A Carpenter; Carina Moravec; Barbara Stehr; Paul J Martin; Perry Rosenthal; Stephen J Forman; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2007-07-20       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.